EMA ‘Trying Its Best’ To Offer More Early Scientific Support For Sponsors

The head of the European Medicines Agency’s scientific advisory office is hopeful that the organization’s PRIME initiative will be enshrined in EU legislation over the coming years, rather than just existing as an initiative from the agency.